Molecular Evidence Platform

Jungla's Molecular Evidence Platform (MEP) is an active learning engine that continuously integrates clinical knowledge to systematically generate, evaluate, audit, and distribute evidence models to partners and clients.

Science & Technology

The Molecular Evidence Platform (MEP) brings together state-of-the-art, large-scale functional (wet lab) and computational (dry lab) methods to inform clinical variant interpretation. This integrated platform allows uniform assessment of the impacts of variants on molecular, cellular, and evolutionary processes.

Performance & Scope

Thoughtful domain-specific specialization and sustained optimization delivers. Jungla's solutions demonstrate prospective accuracy against clinical test results from leading providers and deliver performance that exceeds recommendations from the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) across hundreds of genes and conditions.

Clear & Transparent

With each line of support, the Molecular Evidence Platform (MEP) provides clear, coherent metrics of diagnostic value. These performance metrics as well as the support from all evidence models can be audited via third-party systems to ensure the quality reported is the quality delivered.